Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8
- PMID: 37272794
- PMCID: PMC10308892
- DOI: 10.1128/jvi.00294-23
Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8
Abstract
Serpins are a superfamily of proteins that regulate a variety of physiological processes by irreversibly inhibiting the enzymatic activity of different serine proteases. For example, Serpin Family B Member 8 (Serpin B8, also known as PI8 and CAP2) binds to and inhibits the proprotein convertase furin. Like many other viral pathogens, human immunodeficiency virus type 1 (HIV-1) exploits furin for the proteolytic activation of its envelope glycoprotein (Env). Since the furin inhibitor Serpin B8 is expressed in primary target cells of HIV-1 and induced under inflammatory conditions, we hypothesized that it might interfere with HIV-1 Env maturation and decrease infectivity of newly produced virions. Indeed, recombinant Serpin B8 reduced furin-mediated cleavage of an HIV-1 Env reporter substrate in vitro. However, Serpin B8 did not affect Env maturation or reduce HIV-1 particle infectivity when expressed in HIV-1-producing cells. Immunofluorescence imaging, dimerization assays and in silico sequence analyses revealed that Serpin B8 failed to inhibit intracellular furin since both proteins localized to different subcellular compartments. We therefore aimed at rendering Serpin B8 active against HIV-1 by relocalizing it to furin-containing secretory compartments. Indeed, the addition of a heterologous signal peptide conferred potent anti-HIV-1 activity to Serpin B8 and significantly decreased infectivity of newly produced viral particles. Thus, our findings demonstrate that subcellular relocalization of a cellular protease inhibitor can result in efficient inhibition of infectious HIV-1 production. IMPORTANCE Many cellular proteases serve as dependency factors during viral infection and are hijacked by viruses for the maturation of their own (glyco)proteins. Consequently, inhibition of these cellular proteases may represent a means to inhibit the spread of viral infection. For example, several studies have investigated the serine protease furin as a potential therapeutic target since this protease cleaves and activates several viral envelope proteins, including HIV-1 Env. Besides the development of small molecule inhibitors, cell-intrinsic protease inhibitors may also be exploited to advance current antiviral treatment approaches. Here, we show that Serpin B8, an endogenous furin inhibitor, can inhibit HIV-1 Env maturation and efficiently reduce infectious HIV-1 production when rerouted to the secretory pathway. The results of our study not only provide important insights into the biology of Serpins, but also show how protein engineering of an endogenous furin inhibitor can render it active against HIV-1.
Keywords: Env; Furin; Serpin B8; human immunodeficiency virus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![FIG 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10308892/bin/jvi.00294-23-f001.gif)
![FIG 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10308892/bin/jvi.00294-23-f002.gif)
![FIG 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10308892/bin/jvi.00294-23-f003.gif)
![FIG 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10308892/bin/jvi.00294-23-f004.gif)
![FIG 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10308892/bin/jvi.00294-23-f005.gif)
Similar articles
-
Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras.J Biol Chem. 2013 Jul 26;288(30):21802-14. doi: 10.1074/jbc.M113.462804. Epub 2013 Jun 6. J Biol Chem. 2013. PMID: 23744066 Free PMC article.
-
The Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin.Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10560-5. doi: 10.1073/pnas.0401406101. Epub 2004 Jul 9. Proc Natl Acad Sci U S A. 2004. PMID: 15247425 Free PMC article.
-
Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities.Biol Chem. 2002 Jul-Aug;383(7-8):1067-74. doi: 10.1515/BC.2002.115. Biol Chem. 2002. PMID: 12437089 Review.
-
Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.Biochim Biophys Acta. 2000 Nov 10;1469(3):121-32. doi: 10.1016/s0304-4157(00)00014-9. Biochim Biophys Acta. 2000. PMID: 11063880 Review.
-
Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.J Virol. 1995 May;69(5):3206-10. doi: 10.1128/JVI.69.5.3206-3210.1995. J Virol. 1995. PMID: 7707552 Free PMC article.
Cited by
-
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors.Viruses. 2024 Feb 22;16(3):332. doi: 10.3390/v16030332. Viruses. 2024. PMID: 38543698 Free PMC article. Review.
References
-
- Dittmann M, Hoffmann HH, Scull MA, Gilmore RH, Bell KL, Ciancanelli M, Wilson SJ, Crotta S, Yu Y, Flatley B, Xiao JW, Casanova JL, Wack A, Bieniasz PD, Rice CM. 2015. A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell 160:631–643. doi:10.1016/j.cell.2015.01.040. - DOI - PMC - PubMed
-
- Rosendal E, Mihai IS, Becker M, Das D, Frangsmyr L, Persson BD, Rankin GD, Groning R, Trygg J, Forsell M, Ankarklev J, Blomberg A, Henriksson J, Overby AK, Lenman A. 2022. Serine protease inhibitors restrict host susceptibility to SARS-CoV-2 infections. mBio 13:e0089222. doi:10.1128/mbio.00892-22. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical